Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Clearpoint Neuro Inc (CLPT)

Clearpoint Neuro Inc (CLPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript Motley Fool - Wed Aug 10, 2022

CLPT earnings call for the period ending June 30, 2022.

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Reports Second Quarter 2022 Results Globe Newswire - Tue Aug 9, 2022

Record Quarterly Revenue Achieved; Company Reaffirms 2022 Revenue Forecast...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency Globe Newswire - Thu Jul 21, 2022

First Gene Therapy Approved for Direct Infusion into the Brain will be Administered with ClearPoint’s SmartFlow® Neuro Cannula...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy Globe Newswire - Wed Jun 29, 2022

SOLANA BEACH, Calif., June 29, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency Globe Newswire - Fri May 20, 2022

First Gene Therapy Directly Infused into the Brain to be Administered with ClearPoint’s SmartFlow® Cannula...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC Globe Newswire - Fri May 13, 2022

SOLANA BEACH, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Call Transcript Motley Fool - Wed May 11, 2022

CLPT earnings call for the period ending March 31, 2022.

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Reports First Quarter 2022 Results Globe Newswire - Wed May 11, 2022

SOLANA BEACH, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1 Globe Newswire - Thu Apr 28, 2022

Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022 Globe Newswire - Tue Apr 26, 2022

SOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform...

CLPT : 12.98 (-1.52%)

Barchart Exclusives

3 AI Stocks to Buy Instead of Super Micro Computer Barchart - Sat Aug 31, 7:30AM CDT
Following a significant drop in Super Micro Computer's stock due to a delayed 10-K filing and accounting concerns, investors are exploring alternative AI infrastructure stocks like Dell, Arista Networks, and Pure Storage, which offer strong growth prospects in the rapidly expanding AI market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot